Page last updated: 2024-08-22

molybdenum and disulfiram

molybdenum has been researched along with disulfiram in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Holck, HG; Lish, PM; Malone, MH; Sjogren, DW; Westerfeld, WW1
DoƱate, F; Fruehauf, JP; Lee, K; Mazar, AP; Trapp, V1
Calderon-Aparicio, A; Rieber, M; Strasberg-Rieber, M1
Rieber, M1

Other Studies

4 other study(ies) available for molybdenum and disulfiram

ArticleYear
Effects of disulfiram on growth, longevity, and reproduction of the albino rat.
    Journal of pharmaceutical sciences, 1970, Volume: 59, Issue:9

    Topics: Age Factors; Animals; Ascorbic Acid; Blood Cell Count; Body Weight; Diet; Disulfiram; Female; Growth; Liver; Longevity; Male; Molybdenum; Oxygen Consumption; Rats; Reproduction; Sex Factors; Xanthine Oxidase

1970
Redox-related antimelanoma activity of ATN-224.
    Melanoma research, 2009, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Disulfiram; Drug Synergism; Enzyme Inhibitors; Glutathione; Humans; Melanins; Melanoma; Molybdenum; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Superoxide Dismutase; Temozolomide

2009
Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
    Oncotarget, 2015, Oct-06, Volume: 6, Issue:30

    Topics: Acetylcysteine; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; Disulfiram; Free Radical Scavengers; Humans; Hydrogen Peroxide; MAP Kinase Signaling System; Melanoma; Molybdenum; Mutation, Missense; Proto-Oncogene Proteins B-raf; Reactive Oxygen Species; Receptor, ErbB-2; Superoxide Dismutase

2015
Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Current pharmaceutical design, 2020, Volume: 26, Issue:35

    Topics: Cell Line, Tumor; Copper; Disulfiram; Drug Repositioning; Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species

2020